Frequency of anti-nuclear antibodies in multiple sclerosis

Susan Barned, Andrew D. Goodman, David Mattson

Research output: Contribution to journalArticle

66 Citations (Scopus)

Abstract

We found anti-nuclear antibodies (ANA) in 26.7% of 150 relapsing-remitting and in 30.4% of 23 chronic progressive definite multiple sclerosis (MS) patients bv retromective chart review. These Datients did not have systemic hpus emhemato. Since ANA are not pathogenically relevant in MS, they are false-positive, and likely reflect systemic immune dys-regulation in MS.

Original languageEnglish (US)
Pages (from-to)384-385
Number of pages2
JournalNeurology
Volume45
Issue number2
StatePublished - 1995
Externally publishedYes

Fingerprint

Multiple Sclerosis
Anti-Idiotypic Antibodies
Chronic Progressive Multiple Sclerosis
Charts
Definites

ASJC Scopus subject areas

  • Arts and Humanities (miscellaneous)
  • Clinical Neurology
  • Neuroscience(all)

Cite this

Barned, S., Goodman, A. D., & Mattson, D. (1995). Frequency of anti-nuclear antibodies in multiple sclerosis. Neurology, 45(2), 384-385.

Frequency of anti-nuclear antibodies in multiple sclerosis. / Barned, Susan; Goodman, Andrew D.; Mattson, David.

In: Neurology, Vol. 45, No. 2, 1995, p. 384-385.

Research output: Contribution to journalArticle

Barned, S, Goodman, AD & Mattson, D 1995, 'Frequency of anti-nuclear antibodies in multiple sclerosis', Neurology, vol. 45, no. 2, pp. 384-385.
Barned, Susan ; Goodman, Andrew D. ; Mattson, David. / Frequency of anti-nuclear antibodies in multiple sclerosis. In: Neurology. 1995 ; Vol. 45, No. 2. pp. 384-385.
@article{5ff8d2573e1641c9ae6ae49a6c7acef2,
title = "Frequency of anti-nuclear antibodies in multiple sclerosis",
abstract = "We found anti-nuclear antibodies (ANA) in 26.7{\%} of 150 relapsing-remitting and in 30.4{\%} of 23 chronic progressive definite multiple sclerosis (MS) patients bv retromective chart review. These Datients did not have systemic hpus emhemato. Since ANA are not pathogenically relevant in MS, they are false-positive, and likely reflect systemic immune dys-regulation in MS.",
author = "Susan Barned and Goodman, {Andrew D.} and David Mattson",
year = "1995",
language = "English (US)",
volume = "45",
pages = "384--385",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Frequency of anti-nuclear antibodies in multiple sclerosis

AU - Barned, Susan

AU - Goodman, Andrew D.

AU - Mattson, David

PY - 1995

Y1 - 1995

N2 - We found anti-nuclear antibodies (ANA) in 26.7% of 150 relapsing-remitting and in 30.4% of 23 chronic progressive definite multiple sclerosis (MS) patients bv retromective chart review. These Datients did not have systemic hpus emhemato. Since ANA are not pathogenically relevant in MS, they are false-positive, and likely reflect systemic immune dys-regulation in MS.

AB - We found anti-nuclear antibodies (ANA) in 26.7% of 150 relapsing-remitting and in 30.4% of 23 chronic progressive definite multiple sclerosis (MS) patients bv retromective chart review. These Datients did not have systemic hpus emhemato. Since ANA are not pathogenically relevant in MS, they are false-positive, and likely reflect systemic immune dys-regulation in MS.

UR - http://www.scopus.com/inward/record.url?scp=0028831093&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028831093&partnerID=8YFLogxK

M3 - Article

C2 - 7854544

AN - SCOPUS:0028831093

VL - 45

SP - 384

EP - 385

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 2

ER -